2008
DOI: 10.1016/j.fertnstert.2007.07.1304
|View full text |Cite
|
Sign up to set email alerts
|

Effects of growth hormone and insulin-like growth factor 1 on progesterone production in human luteinized granulosa cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 49 publications
0
12
0
Order By: Relevance
“…Patients underwent in vitro fertilization and embryo transfer (IVF‐ET) with a standardized ovarian‐stimulation protocol as reported previously [31] consisting of GnRH agonist (900 mg/day buserelin acetate, Suprecur; Mochida Pharmaceutical Co. Ltd., Tokyo, Japan) beginning in the mid‐luteal phase, followed by 300 IU follicle stimulating hormone (FSH, Fertinorm P; Serono‐Japan Co. Ltd., Chiba, Japan) on the second and third day, 225 IU FSH on day 4 and 5, and thereafter by 150 IU human menopausal gonadotropins (hMG, HMG‐teizo; Asuka Co. Ltd., Tokyo, Japan). When at least three follicles reached 18 mm or more in diameter by ultrasonography 10,000 IU human chorionic gonadotropin (Gonatropin; Asuka Pharmaceutical Co., Ltd., Tokyo, Japan) was administered and an ultrasound‐guided trans‐vaginal oocyte retrieval was performed 34 hr later.…”
Section: Methodsmentioning
confidence: 99%
“…Patients underwent in vitro fertilization and embryo transfer (IVF‐ET) with a standardized ovarian‐stimulation protocol as reported previously [31] consisting of GnRH agonist (900 mg/day buserelin acetate, Suprecur; Mochida Pharmaceutical Co. Ltd., Tokyo, Japan) beginning in the mid‐luteal phase, followed by 300 IU follicle stimulating hormone (FSH, Fertinorm P; Serono‐Japan Co. Ltd., Chiba, Japan) on the second and third day, 225 IU FSH on day 4 and 5, and thereafter by 150 IU human menopausal gonadotropins (hMG, HMG‐teizo; Asuka Co. Ltd., Tokyo, Japan). When at least three follicles reached 18 mm or more in diameter by ultrasonography 10,000 IU human chorionic gonadotropin (Gonatropin; Asuka Pharmaceutical Co., Ltd., Tokyo, Japan) was administered and an ultrasound‐guided trans‐vaginal oocyte retrieval was performed 34 hr later.…”
Section: Methodsmentioning
confidence: 99%
“…Ovarian stimulation was performed with the long protocol with a GnRH agonist as reported elsewhere (22). The sildenafil suppositories were prepared from the oral tablets.…”
Section: Sildenafil Citrate (Viagra) Treatmentmentioning
confidence: 99%
“…The GH receptor is present in the cumulus cells and oocytes of several species, including human beings [4]. The activity of GH might also influence luteal function, either directly or indirectly, via insulin-like growth factor-1 (IGF-1) [8]. The activity of GH might also influence luteal function, either directly or indirectly, via insulin-like growth factor-1 (IGF-1) [8].…”
Section: Introductionmentioning
confidence: 99%
“…The addition of GH during ovulation induction could optimize the clinical pregnancy rate of IVF and embryo transfer by increasing the number of oocytes retrieved and improving the quality of both eggs and embryos [5][6][7]. The activity of GH might also influence luteal function, either directly or indirectly, via insulin-like growth factor-1 (IGF-1) [8]. By contrast, its effects on endometrial receptivity and implantation remain inconclusive.…”
Section: Introductionmentioning
confidence: 99%